ArticleCureus2025
Clinical Spectrum and Prognostic Predictors of Guillain-Barré Syndrome: A Prospective Observational Study From South India.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionGuillain-Barré syndrome (GBS) is an acute immune-mediated polyradiculoneuropathy and a leading cause of acute flaccid paralysis. Though uncommon, it carries substantial morbidity and mortality. Indian prospective data remain limited, prompting this study to evaluate clinical patterns, complications, and prognostic determinants in a tertiary care cohort. STUDY: This prospective observational study was conducted at Madras Medical College, Chennai, between May 2024 and May 2025. Ninety consecutive patients aged 12 years and above fulfilling the Asbury and Cornblath criteria for GBS were included. Clinical details, cerebrospinal fluid (CSF) parameters, and electrophysiological subtypes were documented. Patients received intravenous immunoglobulin (IVIG), plasma exchange (PLEX), or supportive care. Outcomes assessed were ventilation requirement, complications, mortality, and functional status at discharge using the modified Rankin Scale (mRS).
resultsNinety patients (mean age 38.5 years) were studied, with a slight male predominance. Antecedent infections were common, mainly respiratory or gastrointestinal. Most patients (over 80%) presented with ascending symmetrical weakness, predominantly of the pure motor type. Acute inflammatory demyelinating polyradiculoneuropathy (AIDP) was the commonest electrophysiological subtype, followed by axonal variants. About one-fourth required intensive care unit (ICU) admission, and one-fifth needed mechanical ventilation. At discharge, one-third regained independent ambulation, while 9% died. Poor outcomes were associated with older age, cranial nerve and autonomic involvement, and axonal forms.
conclusionGBS in this cohort predominantly affected young to middle-aged adults, with classical ascending weakness and AIDP as the commonest pattern, though axonal forms were frequent. One-third recovered well, but nearly half remained disabled and 9% died. Early recognition of predictors such as older age, cranial nerve palsy, autonomic dysfunction, and axonal subtypes is crucial for risk stratification and intensive management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.